- Home
- PRLD vs SPCB Comparison
PRLD vs SPCB Comparison
Compare PRLD & SPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRLD
- SPCB
- Stock Information
- Founded
- PRLD 2016
- SPCB 1988
- Country
- PRLD United States
- SPCB Israel
- Employees
- PRLD N/A
- SPCB N/A
- Industry
- PRLD Medicinal Chemicals and Botanical Products
- SPCB Semiconductors
- Sector
- PRLD Health Care
- SPCB Technology
- Exchange
- PRLD Nasdaq
- SPCB Nasdaq
- Market Cap
- PRLD 69.1M
- SPCB 57.7M
- IPO Year
- PRLD 2020
- SPCB N/A
- Fundamental
- Price
- PRLD $1.42
- SPCB $10.69
- Analyst Decision
- PRLD Strong Buy
- SPCB Strong Buy
- Analyst Count
- PRLD 3
- SPCB 1
- Target Price
- PRLD $4.00
- SPCB $18.00
- AVG Volume (30 Days)
- PRLD 290.5K
- SPCB 119.8K
- Earning Date
- PRLD 11-05-2025
- SPCB 11-13-2025
- Dividend Yield
- PRLD N/A
- SPCB N/A
- EPS Growth
- PRLD N/A
- SPCB N/A
- EPS
- PRLD N/A
- SPCB 0.98
- Revenue
- PRLD $7,000,000.00
- SPCB $27,426,000.00
- Revenue This Year
- PRLD N/A
- SPCB N/A
- Revenue Next Year
- PRLD N/A
- SPCB $29.31
- P/E Ratio
- PRLD N/A
- SPCB $11.35
- Revenue Growth
- PRLD N/A
- SPCB 2.17
- 52 Week Low
- PRLD $0.61
- SPCB $2.97
- 52 Week High
- PRLD $2.08
- SPCB $18.95
- Technical
- Relative Strength Index (RSI)
- PRLD 60.29
- SPCB 51.12
- Support Level
- PRLD $1.33
- SPCB $10.60
- Resistance Level
- PRLD $1.63
- SPCB $12.00
- Average True Range (ATR)
- PRLD 0.18
- SPCB 0.70
- MACD
- PRLD 0.01
- SPCB -0.18
- Stochastic Oscillator
- PRLD 49.42
- SPCB 22.61
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About SPCB SuperCom Ltd. (Israel)
SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.